Aarti Drugs is currently trading at Rs. 538.10, up by 1.10 points or 0.20% from its previous closing of Rs. 537.00 on the BSE.
The scrip opened at Rs. 536.80 and has touched a high and low of Rs. 545.30 and Rs. 536.60 respectively. So far 1427 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 10 has touched a 52 week high of Rs. 705.00 on 11-Mar-2019 and a 52 week low of Rs. 419.30 on 05-Aug-2019.
Last one week high and low of the scrip stood at Rs. 556.25 and Rs. 512.00 respectively. The current market cap of the company is Rs. 1253.54 crore.
The promoters holding in the company stood at 61.64%, while Institutions and Non-Institutions held 5.35% and 33.01% respectively.
Aarti Drugs has incorporated a marketing subsidiary namely ‘Pinnacle Chile SpA’ in Chile. The said company is incorporated for marketing the formulation drugs and participating in tender and private market in Chile.
Aarti Drugs is engaged in the business of manufacturing generic bulk actives, advanced intermediates and specialty chemicals.